Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CureVac N.V.

    NASDAQ: CVAC · Real-Time Price · USD
    5.40
    -0.04 (-0.74%)
    At close: Jun 26, 2025, 3:59 PM
    5.35
    -0.93%
    After-hours: Jun 26, 2025, 07:45 PM EDT

    CureVac Statistics

    Share Statistics

    CureVac has 225.17M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 225.17M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 3.5%

    Shares Floating

    n/a
    		 95.51M

    Failed to Deliver (FTD) Shares

    n/a
    		 118,432

    FTD / Avg. Volume

    n/a
    		 10.16%

    Short Selling Information

    The latest short interest is 4.2M, so 1.87% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.2M

    Short % of Shares Out

    n/a
    		 1.87%

    Short % of Float

    n/a
    		 10.46%

    Short Ratio (days to cover)

    n/a
    		 4.32

    Valuation Ratios

    The PE ratio is 4.56 and the forward PE ratio is -10.74. CureVac's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 4.56

    Forward PE

    n/a
    		 -10.74

    PS Ratio

    n/a
    		 1.38

    Forward PS

    n/a
    		 5.1

    PB Ratio

    n/a
    		 1.06

    P/FCF Ratio

    n/a
    		 8.86

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    CureVac has an Enterprise Value (EV) of 296.1M.

    EV / Sales

    n/a
    		 0.55

    EV / EBITDA

    n/a
    		 1.41

    EV / EBIT

    n/a
    		 2.91

    EV / FCF

    n/a
    		 3.55

    Financial Position

    The company has a current ratio of 7.28, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 7.28

    Quick Ratio

    n/a
    		 7.27

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 0.19

    Debt / FCF

    n/a
    		 0.47

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 23.28% and Return on Invested Capital is 20.52%.

    Return on Equity

    n/a
    		 23.28%

    Return on Assets

    n/a
    		 20.2%

    Return on Invested Capital

    n/a
    		 20.52%

    Revenue Per Employee

    n/a
    		 $648,703.03

    Profits Per Employee

    n/a
    		 $196,589.09

    Employee Count

    n/a
    		 825

    Asset Turnover

    n/a
    		 0.67

    Inventory Turnover

    n/a
    		 195.62

    Taxes

    Income Tax

    n/a
    		 28.7M

    Effective Tax Rate

    n/a
    		 15.03%

    Stock Price Statistics

    The stock price has increased by 60.83% in the last 52 weeks. The beta is 2.49, so CureVac's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.49

    52-Week Price Change

    n/a
    		 60.83%

    50-Day Moving Average

    n/a
    		 4.09

    200-Day Moving Average

    n/a
    		 3.38

    Relative Strength Index (RSI)

    n/a
    		 66.96

    Average Volume (20 Days)

    n/a
    		 1,165,561

    Income Statement

    In the last 12 months, CureVac had revenue of 535.18M and earned 162.19M in profits. Earnings per share was 0.72.

    Revenue

    n/a
    		 535.18M

    Gross Profit

    n/a
    		 429.35M

    Operating Income

    n/a
    		 177.68M

    Net Income

    n/a
    		 162.19M

    EBITDA

    n/a
    		 209.69M

    EBIT

    n/a
    		 190.88M

    Earnings Per Share (EPS)

    n/a
    		 0.72
    Full Income Statement

    Balance Sheet

    The company has 481.75M in cash and 38.97M in debt, giving a net cash position of 442.78M.

    Cash & Cash Equivalents

    n/a
    		 481.75M

    Total Debt

    n/a
    		 38.97M

    Net Cash

    n/a
    		 442.78M

    Retained Earnings

    n/a
    		 -1.4B

    Total Assets

    n/a
    		 802.83M

    Working Capital

    n/a
    		 454.07M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 101.85M and capital expenditures -18.44M, giving a free cash flow of 83.41M.

    Operating Cash Flow

    n/a
    		 101.85M

    Capital Expenditures

    n/a
    		 -18.44M

    Free Cash Flow

    n/a
    		 83.41M

    FCF Per Share

    n/a
    		 0.37
    Full Cash Flow Statement

    Margins

    Gross margin is 80.23%, with operating and profit margins of 33.2% and 30.3%.

    Gross Margin

    n/a
    		 80.23%

    Operating Margin

    n/a
    		 33.2%

    Pretax Margin

    n/a
    		 35.67%

    Profit Margin

    n/a
    		 30.3%

    EBITDA Margin

    n/a
    		 39.18%

    EBIT Margin

    n/a
    		 33.2%

    FCF Margin

    n/a
    		 15.58%

    Dividends & Yields

    CVAC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 21.95%

    FCF Yield

    n/a
    		 11.29%
    Dividend Details

    Analyst Forecast

    The average price target for CVAC is $10, which is 84.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 84.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 7.11

    Graham Upside

    n/a
    		 31.18%

    Scores

    Altman Z-Score

    n/a
    		 5.3

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist